Early research (Phase 1)Active Not RecruitingNCT05618028
What this trial is testing
Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets
Who this might be right for
Diffuse Large B-Cell LymphomaChronic Lymphocytic LeukemiaB Cell Malignancies+1 more
AbbVie 78